Everence Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,080
| Closed | -$115K | – | 747 |
|
|
2023
Q2 | $115K | Hold |
28,080
| – | – | 0.01% | 712 |
|
|
2023
Q1 | $192 | Hold |
28,080
| – | – | 0.02% | 693 |
|
|
2022
Q4 | $222 | Hold |
28,080
| – | – | 0.02% | 652 |
|
|
2022
Q3 | $270K | Hold |
28,080
| – | – | 0.03% | 543 |
|
|
2022
Q2 | $203K | Buy |
28,080
+16,390
| +140% | +$118K | 0.02% | 641 |
|
|
2022
Q1 | $151K | Hold |
11,690
| – | – | 0.01% | 718 |
|
|
2021
Q4 | $187K | Hold |
11,690
| – | – | 0.01% | 737 |
|
|
2021
Q3 | $188K | Hold |
11,690
| – | – | 0.02% | 704 |
|
|
2021
Q2 | $162K | Hold |
11,690
| – | – | 0.01% | 717 |
|
|
2021
Q1 | $171K | Hold |
11,690
| – | – | 0.02% | 700 |
|
|
2020
Q4 | $203K | Hold |
11,690
| – | – | 0.02% | 645 |
|
|
2020
Q3 | $214K | Buy |
+11,690
| New | +$214K | 0.02% | 564 |
|